A new company, a spin-off from another of Dr. Robert Langer’s MIT companies, has just come out of stealth mode and released details of its potentially breakthrough approach to delivering drugs on demand to the back of the eye. The new company, On Demand Therapeutics, has disclosed a laser activatable drug reservoir that can deliver a drug such as Avastin, for treating neovascular AMD, as needed to treat that disease. At least, that is the concept.

To read more about this potential breakthrough in on-demand drug delivery, please see my writeup ^[1] on the company, including illustrations of the concept, along with several questions I have.